第一作者:
Maija L,Castrén
第一单位:
Institute of Biomedicine/Physiology, University of Helsinki, P.O. Box 63, FIN-00014 Helsinki, Finland; Rinnekoti Foundation, Rinnekodintie 10, FIN-02980 Espoo, Finland. Electronic address: Maija.Castren@helsinki.fi.
作者:
关键词
2-methyl-6-(phenylethynyl)pyridine hydrochlorideADHDAutismBDNFBrain-derived neurotrophic factorCYFIP1Circuit functionDifferentiationFMR1 geneFMR1 proteinFMRPFMRP-interacting proteinFXSFXTASFmr1 KOFmr1 geneFragile X syndromeGABAIPLTDLTPMPEPMental retardationN-methyl-d-aspartate receptorNMDANPCNeural progenitorsRNA interferenceRNAiTrkB receptoraNPCsadult neural progenitor cellsattention deficit and/or hyperactive disorderfragile X mental retardation 1 genefragile X mental retardation 1 knockoutgamma-aminobutyric acidgp1group 1intermediate progenitorlong-term depressionlong-term potentiationmGluRmetabotropic glutamate receptorneural progenitor cellstremor/ataxia syndrometropomyosin-related kinase B receptor
医学主题词
动物(Animals);脑源性神经营养因子(Brain-Derived Neurotrophic Factor);脆性X智力低下蛋白质(Fragile X Mental Retardation Protein);脆性X综合征(Fragile X Syndrome);基因表达调控, 发育期(Gene Expression Regulation, Developmental);人类(Humans);小鼠(Mice);受体, trkB(Receptor, trkB);信号传导(Signal Transduction)
DOI
10.1016/j.neuropharm.2013.05.018
PMID
23727436
发布时间
2013-12-09
- 浏览44
Neuropharmacology
729-36页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



